Marketing Manager, Downstream Marketing

Palo Alto, CA (On-site)

$166K/yr – $188K/yrMid Level5+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive cross-functional commercialization for a cardiovascular therapy with omnichannel and lead-generation focus.

  • Own omnichannel lead generation and integrated digital campaigns.
  • Must-have: 5+ years of life sciences marketing with omnichannel execution.
  • Standout: Interventional cardiology or cardiovascular devices experience and cross-functional leadership.

Job Description

Own end-to-end commercialization for a cardiovascular therapy via omnichannel and lead-generation programs.

  • Lead omnichannel commercialization and lead-generation programs across digital, events, and field engagement.
  • Must-have: 5+ years of life sciences marketing with omnichannel/digital execution.
  • Standout: Experience in interventional cardiology or cardiovascular medical devices and cross-functional leadership.
Recor Medical logo

Recor Medical

2.9 Glassdoor

Recor Medical, headquartered in Palo Alto, Calif., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise system is FDA approved in the United States, bears the CE mark, and is an investigational device in Japan,

Founded in 2009
Palo Alto, California, USA
313 employees (10 in marketing)
40% recommend to a friend
72% CEO approval

Traffic Signals

Monthly Visitors
7.7K
Traffic Source Mix
Search
28.4%
Direct
47.5%
Referral
6.6%
Social
15.9%
Paid
1.5%

Headcount Trend

Current headcount: ~313

Marketing Team

Marketing Team Size
10 (3% of company)
Median Career Experience
19 years
Median Tenure
3.2 years

Funding

Total Funding
$25M
Last Raise
$10M
Debt Financing, 10 years ago

Funding History

  • Jun 2016
    Debt Financing • $10M
  • Apr 2015
    Series D • $15M

Recent News